| Issue Type | XXXX |
|---|---|
| Country | Ireland |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2039-03-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 157.63 |
| Coupon | 6.5 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 300 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Medtronic Plc corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million USD and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Medtronic Plc, founded in 1949 and headquartered in Dublin, Ireland, is a global leader in medical technology, offering innovative healthcare solutions aimed at alleviating pain, restoring health, and extending life. The company specializes in developing and manufacturing a wide array of medical devices and therapies for various chronic diseases, including diabetes management products, cardiovascular devices, and surgical equipment.